Literature DB >> 29987690

Hyperbaric Oxygen Protects Against Cerebral Damage in Permanent Middle Cerebral Artery Occlusion Rats and Inhibits Autophagy Activity.

KongMiao Lu1,2, HaiRong Wang1, XiaoLi Ge1, QingHua Liu1, Miao Chen1, Yong Shen1, Xuan Liu1, ShuMing Pan3.   

Abstract

BACKGROUND: To investigate the effects of hyperbaric oxygen (HBO) on brain damage and autophagy levels in a rat model of middle cerebral artery occlusion.
METHODS: Neurologic injury and infarcted areas were evaluated according to the modified neurological severity score and 2,3,5-triphenyltetrazolium chloride staining. Western blots were used to determine beclin1, caspase-3 and fodrin1 protein expression. Beclin1 protein expression (an autophagy marker), positive terminal dUTP nick-end labeling (TUNEL) staining (an apoptosis marker) and positive propidium iodide (PI) staining (a necrosis marker) were detected by immunofluorescence.
RESULTS: Our results indicated that HBO could decrease the infarct volume and speed up the recovery of the neurological deficit scores in ischemic rats. Beclin1 was down-regulated after HBO treatment. HBO treatment inhibited fodrin1 protein expression and decreased the number of PI-positive cells. HBO also down-regulated caspase-3 and decreased the number of TUNEL-positive cells.
CONCLUSION: Cerebral ischemia caused early neuronal death due to necrosis, followed by delayed neuronal death due to apoptosis. Consequently, autophagy might be involved in all processes of ischemia. HBO could protect the brain against ischemic injury, and the possible mechanisms might be correlated with decreased autophagy activity and decreased apoptosis and necrosis levels.

Entities:  

Keywords:  Apoptosis; Autophagy; Cerebral infarction; Hyperbaric oxygen; Necrosis

Mesh:

Year:  2019        PMID: 29987690     DOI: 10.1007/s12028-018-0577-x

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN: 1541-6933            Impact factor:   3.210


  34 in total

1.  Beclin-phosphatidylinositol 3-kinase complex functions at the trans-Golgi network.

Authors:  A Kihara; Y Kabeya; Y Ohsumi; T Yoshimori
Journal:  EMBO Rep       Date:  2001-04       Impact factor: 8.807

Review 2.  Autophagy in health and disease: a double-edged sword.

Authors:  Takahiro Shintani; Daniel J Klionsky
Journal:  Science       Date:  2004-11-05       Impact factor: 47.728

Review 3.  Self-eating and self-killing: crosstalk between autophagy and apoptosis.

Authors:  M Chiara Maiuri; Einat Zalckvar; Adi Kimchi; Guido Kroemer
Journal:  Nat Rev Mol Cell Biol       Date:  2007-09       Impact factor: 94.444

4.  Hyperbaric Oxygenation Protects Against Ischemia-Reperfusion Injury in Transplanted Rat Kidneys by Triggering Autophagy and Inhibiting Inflammatory Response.

Authors:  Ding-Su Bao; Yu-Ke Wu; Shi-Jie Fu; Guo-You Wang; Si-Jin Yang; Guo-Biao Liang; Zhi-Hui Xie; Song Rong
Journal:  Ann Transplant       Date:  2017-02-10       Impact factor: 1.530

5.  Specific caspase inhibitor Q-VD-OPh prevents neonatal stroke in P7 rat: a role for gender.

Authors:  Sylvain Renolleau; Sébastien Fau; Catherine Goyenvalle; Luc-Marie Joly; David Chauvier; Etienne Jacotot; Jean Mariani; Christiane Charriaut-Marlangue
Journal:  J Neurochem       Date:  2006-12-12       Impact factor: 5.372

6.  Caspase inhibition after neonatal ischemia in the rat brain.

Authors:  Luc-Marie Joly; Valérie Mucignat; Jean Mariani; Michel Plotkine; Christiane Charriaut-Marlangue
Journal:  J Cereb Blood Flow Metab       Date:  2004-01       Impact factor: 6.200

Review 7.  Hyperbaric oxygen therapy and cerebral ischemia: neuroprotective mechanisms.

Authors:  Gerald A Matchett; Robert D Martin; John H Zhang
Journal:  Neurol Res       Date:  2009-03       Impact factor: 2.448

8.  Apoptotic mitochondrial pathway in neurones and astrocytes after neonatal hypoxia-ischaemia in the rat brain.

Authors:  N Benjelloun; L-M Joly; B Palmier; M Plotkine; C Charriaut-Marlangue
Journal:  Neuropathol Appl Neurobiol       Date:  2003-08       Impact factor: 8.090

9.  Hyperbaric oxygen enlarges the area of brain damage in MCAO rats by blocking autophagy via ERK1/2 activation.

Authors:  Yuxiong Lu; Jinsong Kang; Yang Bai; Yu Zhang; Hongyan Li; Xiaochun Yang; Xiyan Xiang; Xinxue Wang; Yuanping Huang; Jing Su; Ye Chen; Bingjin Li; Liankun Sun
Journal:  Eur J Pharmacol       Date:  2014-02-07       Impact factor: 4.432

Review 10.  Stroke.

Authors:  Geoffrey A Donnan; Marc Fisher; Malcolm Macleod; Stephen M Davis
Journal:  Lancet       Date:  2008-05-10       Impact factor: 79.321

View more
  6 in total

Review 1.  Recent advances in the neuroprotective effects of medical gases.

Authors:  Yue-Zhen Wang; Ting-Ting Li; Hong-Ling Cao; Wan-Chao Yang
Journal:  Med Gas Res       Date:  2019 Apr-Jun

2.  Hyperbaric Oxygen Improves Cerebral Ischemia/Reperfusion Injury in Rats Probably via Inhibition of Autophagy Triggered by the Downregulation of Hypoxia-Inducing Factor-1 Alpha.

Authors:  Cuiting Wang; Feng Niu; Ningna Ren; Xiaokun Wang; Hequan Zhong; Jie Zhu; Bing Li
Journal:  Biomed Res Int       Date:  2021-03-15       Impact factor: 3.411

Review 3.  The Role of Ubiquitin-Proteasome Pathway and Autophagy-Lysosome Pathway in Cerebral Ischemia.

Authors:  Chunli Chen; Haiyun Qin; Jieqiong Tan; Zhiping Hu; Liuwang Zeng
Journal:  Oxid Med Cell Longev       Date:  2020-01-30       Impact factor: 6.543

4.  Effects of Snake-Derived Phospholipase A2 Inhibitors on Acute Pancreatitis: In vitro and in vivo Characterization.

Authors:  Yanping Wu; Gen-You Liao; Hua-Jing Ke; Pi Liu
Journal:  Drug Des Devel Ther       Date:  2020-11-06       Impact factor: 4.162

Review 5.  An Extra Breath of Fresh Air: Hyperbaric Oxygenation as a Stroke Therapeutic.

Authors:  Blaise Cozene; Nadia Sadanandan; Bella Gonzales-Portillo; Madeline Saft; Justin Cho; You Jeong Park; Cesar V Borlongan
Journal:  Biomolecules       Date:  2020-09-04

6.  Normobaric Oxygen (NBO) Therapy Reduces Cerebral Ischemia/Reperfusion Injury through Inhibition of Early Autophagy.

Authors:  Meng Wang; Xiaokun Geng; Chaitu Dandu; Radhika Patel; Yuchuan Ding
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-30       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.